Basics |
Atyr Pharma, Inc.
|
IPO Date: |
May 12, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$471.72M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.11 | 3.45%
|
Avg Daily Range (30 D): |
$0.19 | 3.71%
|
Avg Daily Range (90 D): |
$0.16 | 4.10%
|
Institutional Daily Volume |
Avg Daily Volume: |
.12M |
Avg Daily Volume (30 D): |
2.91M |
Avg Daily Volume (90 D): |
1.9M |
Trade Size |
Avg Trade Size (Sh.): |
164 |
Avg Trade Size (Sh.) (30 D): |
164 |
Avg Trade Size (Sh.) (90 D): |
158 |
Institutional Trades |
Total Inst.Trades: |
53 |
Avg Inst. Trade: |
$2.38M |
Avg Inst. Trade (30 D): |
$2.68M |
Avg Inst. Trade (90 D): |
$2.3M |
Avg Inst. Trade Volume: |
.61M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.21M |
Avg Closing Trade (30 D): |
$4.07M |
Avg Closing Trade (90 D): |
$3.45M |
Avg Closing Volume: |
653.81K |
|
|
Financials |
|
TTM |
FY 2024 |
Q3 2024 |
Basic EPS
|
$-.17
|
$-.86
|
$-.23
|
Diluted EPS
|
$-.17
|
$-.86
|
$-.23
|
Revenue
|
$ M
|
$ .24M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.88M
|
$ -64.02M
|
$ -17.26M
|
Operating Income / Loss
|
$ -15.77M
|
$ -67.91M
|
$ -18.14M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.21M
|
$ -12.02M
|
$ 4.68M
|
PE Ratio
|
|
|
|
|
|
|